Advil Congestion effort ties traffic gridlock to cold and flu misery

Share this article:
Advil Congestion effort ties traffic gridlock to cold and flu misery
Advil Congestion effort ties traffic gridlock to cold and flu misery
Don't tell the New York Post, but Pfizer is boosting bike lanes as part of an Advil promotion.

Pfizer Consumer Healthcare donated special snow removal equipment for bike lanes to Chicago, which ranks Number One in the country for traffic congestion, to promote Advil Congestion Relief. Chicago Bears legend and Pro Football Hall of Famer Richard Dent presided over the giveaway of the equipment and 100 new bikes last week. The company is running ads for the brand under the tagline “The Right Relief for the Real Problem, and will be holding similar events in communities around the country as part of its Advil Congestion Relief Project this winter. Visitors to the campaign website, CongestionReliefProject.com, can share their community's congestion relief needs for a chance to win $30,000 towards local congestion relief efforts.

“We are passionate about finding the right relief for the real problem for consumers wherever they need it, from their noses to their communities,” said Kristin Shea, franchise head for upper respiratory and allergy at Pfizer Consumer Healthcare. “We're excited to be hitting the road with the Advil Congestion Relief Project this cold and flu season and look forward to seeing the stories our consumers will share with us about their communities.
Share this article:

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union